Nonetheless, anti-IL-33 may provide a new treatment strategy for targeting infiltrating neutrophils in CRSwNP due to the demonstrated role that IL-33 has in neutrophil recruitment. The gene discussed is IL33; the disease is chronic rhinosinusitis with nasal polyps.